Christopher Austin is the founder of Vesalius Therapeutics. Vesalius Therapeutics has raised $75M in total funding. Latest round: Series A.
Christopher Austin is a co-founder of Vesalius Therapeutics, a biotechnology company founded in 2019 by Flagship Pioneering. Vesalius Therapeutics focuses on developing breakthrough treatments for prevalent human diseases by systematically identifying the fundamental causal biology and underlying drivers of complex conditions. The company has raised $75 million in Series A funding in March 2022. Austin, who previously served as the founding director of the National Center for Advancing Translational Sciences within the National Institutes of Health, co-founded Vesalius with Doug Cole.
Full founder directory · Investor directory · Company funding database · Fundraising library